MobileODT
Liger Medical develops breakthrough optical diagnostic devices and software for early cancer detection and other medical purposes.
About
Liger Medical, formerly MobileODT, is dedicated to delivering affordable and practical healthcare innovation. They achieve this by creating advanced optical diagnostic devices and software services primarily focused on early cancer detection, with plans to expand into a range of other medical applications. Teams look it up for Healthcare, Medical Imaging, Cancer.
Frequently asked
What does MobileODT do?
MobileODT is a Healthcare company that offers Hardware, Software. Teams look it up for Medical Imaging, Cancer, Clinical. It is based in Tel Aviv, Israel and was founded in 2012. Public records show about 9 people and $14M raised. Compare it on funding, headcount, reviews and nearby alternatives rather than the marketing line alone.
How much funding has MobileODT raised?
MobileODT has raised a total of $14M in funding. The most recent round on record is Grant.
Where is MobileODT headquartered?
MobileODT is headquartered in Tel Aviv, Israel.
When was MobileODT founded?
MobileODT was founded in 2012.
What industry does MobileODT operate in?
MobileODT operates in Healthcare, Medical Imaging, Cancer, Clinical, Camera.
How many employees does MobileODT have?
MobileODT has approximately 9 people on record.
Strength of the site’s backlink profile, on Ahrefs’ 0-100 Domain Rating scale. Licensed third-party data, not our opinion.
How well an AI agent can read and use this site: structured data, clean markup, and whether key facts are reachable without running JavaScript. We scan the live site.
Google PageSpeed mobile performance for the company’s own site. Measured by Google, not by us.
“Interview: MobileODT using AWS cloud to save lives.”
View on Reddit“[N] Intel & MobileODT Cervical Cancer Screening - Image Classification Competition.”
View on RedditSome comments are pulled from public discussions around the web (look for the source icon). Quotes are excerpts; click through to read the full thread.